Ireps

AOC

Goods

Anti -Cancer Medicines

Central Railway

Maharashtra

Amount: Refer DocsCloses: 2 Apr 2026Closed

Timeline

Published25 Mar 2026
Closed2 Apr 2026
Awarded—

Tender Value

Refer Docs

Closing Date

2 Apr 2026, 11:00 amClosed

Bidding Terms

Bidding System

Single Packet

Tender Mode

Normal Tender

Pre-Bid Conference

Pre-Bid Conference On

Not Applicable

Evaluation Criteria

Itemwise/Consigneewise

Ranking Order

Lowest to Highest

Inspection Agency

CONSIGNEE

Approving Agency

Not Applicable

Offer Validity

90 days

Contract Category

Expenditure

Item Category

General

Tendering Section

PUR

Eligibility Criteria

1 condition

Special Eligibility Criteria

1
Product registered with Railway Board Manufacturing firms are eligible.
Confirmation required

Compliance & Declarations

9 conditions

Check List

1
NA

Commercial-Compliance

1
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions
Confirmation required
2
VERY IMPORTANT:- PLEASE GIVE THE BRAND NAME, OWN/THIRD PARTY MANUFACTURING, MRP, HSN CODE OF THE PRODUCT, NAME AND ADDRESS OF AUTHORISED DISTRIBUTOR, PURCHASE ORDER COPY OF GOVERNMENT INSTITUTION
Confirmation required
3
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
Document optional

Bid Responsiveness

3 conditions

1
Payment Terms: No deviation from the Payment Terms stipulated in the tender is permitted.
2
Validity of Offer: No deviation from the offer validity period stipulated in the tender is permitted.
3
Delivery Period: No deviation from the Delivery Period stipulated in the tender is permitted.

Delivery Locations

1 location across Maharashtra · 2,466 Numbers total

Divisional Rly Hospital, NGP, CRMaharashtra

2466 Numbers

Delivery & Payment Terms

F.O.R

Destination

Delivery Period

For all items — Completion : Within 1 Months

Payment Terms

100% payment against receipt, inspection and acceptance of material by the consignee at destination.

Statutory Variation Clause

Statutory Variation in taxes and duties, or fresh imposition of taxes and duties by State/ Central Governments in respect of the items stipulated in the contract (and not the raw materials thereof), within the original delivery period stipulated in the contract, or last unconditionally extended delivery period shall be to Railways' account. Only such variation shall be admissible which takes place after the submission of bid. No claim on account of statutory variation in respect of existing tax/duty will be accepted unless the tenderer has clearly indicated in his offer the rate of tax/duty considered in his quoted rate. No claim on account of statutory variation shall be admissible on account of misclassification by the supplier/ contractor.

Option Clause

The purchaser shall be entitled to vary the order quantity upto +/- 30% anytime within the delivery period (including extended delivery period) on the same terms and conditions. The increase in quantity with respect to the tender quantity can be done even at the time of ordering and the tenderer shall be bound to accept the quantity so ordered on the basis of his original offer. The purchaser shall be entitled to exercise +/- 30% option clause in one or more than one instalment as long as the total variation in quantity does not exceed the limit of 30% of ordered quantity.

Railway Standard Fall Clause

Railway Standard Fall Clause shall be applicable.

Standard Governing Conditions

FOR destination
IRS Conditions of Contract: The contract shall be governed by latest version (along with all correction slips) of IRS conditions of contract, and all other terms and conditions incorporated in the tender documents.

Work Description

Anti -Cancer Medicines

Tender Information

Tender ID

H6261109

Reference Number

H6261109

Tender Type

Limited - Indigenous

Form of Contract

Goods

Location

Maharashtra

Source Website

Subscribe to view

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

Exempted

Important Dates

Last Activity

2 Apr 2026

Published

25 Mar 2026

Items & Quantities

4 items · 2,466 Numbers total

PL 82028710Goods (Y)

26025 - INJ OCTREOTIDE LAR 30 MIU ]

Inspection Agency: CONSIGNEE
Stock Type: ---
Considered for Evaluation: Yes

Delivery Location	State	Quantity
Divisional Rly Hospital, NGP, CR	Maharashtra	6.00 Numbers
Total		6 Numbers

PL 82050144Goods (Y)

26016 - TAB. TOFACITINIB 5 MG ]

Inspection Agency: CONSIGNEE
Stock Type: ---
Considered for Evaluation: Yes

Delivery Location	State	Quantity
Divisional Rly Hospital, NGP, CR	Maharashtra	600.00 Numbers
Total		600 Numbers

PL 82052256Goods (Y)

17763 - TAB IBRUTINIB 140 MG ]

Inspection Agency: CONSIGNEE
Stock Type: ---
Considered for Evaluation: Yes

Delivery Location	State	Quantity
Divisional Rly Hospital, NGP, CR	Maharashtra	360.00 Numbers
Total		360 Numbers

PL 82191060Goods (Y)

91060 - CAP. NINTEDANIB ESYLATE 150 MG ]

Inspection Agency: CONSIGNEE
Stock Type: ---
Considered for Evaluation: Yes

Delivery Location	State	Quantity
Divisional Rly Hospital, NGP, CR	Maharashtra	1500.00 Numbers
Total		1,500 Numbers

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

HTML

NIT Documents

nit.pdf

NIT

Work Item Documents

5723107.pdf

ATTACHMENT

5726418.pdf

ATTACHMENT

5726415.pdf

ATTACHMENT

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].